Related Experiment Videos
Cerebrospinal fluid oligoclonal IgM in multiple sclerosis: analytical problems and clinical limitations
Insights
This study details a new method for detecting oligoclonal IgM in cerebrospinal fluid (CSF). While useful, it is less sensitive and specific than oligoclonal IgG testing for diagnosing multiple sclerosis (MS).
Area of Science:
- Neuroimmunology
- Biochemical diagnostics
Background:
- Oligoclonal bands in cerebrospinal fluid (CSF) are key biomarkers for neurological diseases, particularly multiple sclerosis (MS).
- While oligoclonal immunoglobulin G (IgG) is routinely assessed, the diagnostic role of oligoclonal immunoglobulin M (IgM) remains less defined.
Purpose of the Study:
- To describe and validate a novel method for detecting oligoclonal IgM in CSF.
- To evaluate the diagnostic utility of CSF oligoclonal IgM in comparison to oligoclonal IgG, especially for multiple sclerosis (MS).
Main Methods:
- Development of a sensitive assay using agarose isoelectric focusing, poly(vinyl difluoride) blotting, and double-antibody immunoperoxidase staining with avidin-biotin amplification for CSF IgM.
- Implementation of specific conditions to prevent cross-reactivity with IgG.
- Application of the method to 99 patients, including those with and without MS, and comparison with existing oligoclonal IgG analysis.
Main Results:
- The assay successfully detected oligoclonal IgM in CSF.
- Positive oligoclonal IgM results were found in 17/27 patients with oligoclonal IgG and in 2/72 patients without oligoclonal IgG.
- Oligoclonal IgM was not detected in MS patients lacking oligoclonal IgG, but was present in some non-MS patients with oligoclonal IgG.
- CSF oligoclonal IgM demonstrated lower sensitivity and did not improve specificity compared to CSF oligoclonal IgG for MS diagnosis.
Conclusions:
- The described method reliably detects CSF oligoclonal IgM.
- CSF oligoclonal IgM is less sensitive and specific than oligoclonal IgG for diagnosing multiple sclerosis (MS).
- Oligoclonal IgM may be present in other neurological conditions associated with oligoclonal IgG.
Abstract:
A method for detecting cerebrospinal fluid (CSF) oligoclonal IgM is described. Concentrated CSF was separated by agarose isoelectric-focusing and blotted with poly(vinyldifluoride). A double-antibody immunoperoxidase technique with avidin-biotin amplification was used to stain IgM. Special conditions were required to avoid cross-reaction with IgG. The method was applied to 99 patients on whom oligoclonal IgG analysis was performed. Positive IgM results occurred in 17 of the 27 patients positive for oligoclonal IgG, and in two patients negative for oligoclonal IgG, neither of whom had multiple sclerosis (MS). Fifteen of the patients positive for oligoclonal IgM had some IgM bands in their sera. Oligoclonal IgM was not found in the CSF of suspected MS patients without oligoclonal IgG, but occurred in several patients with oligoclonal IgG due to other diseases. As a test for MS, oligoclonal IgM was less sensitive than oligoclonal IgG and did not improve specificity.